Jon S Odorico, MD


  • Section of Kidney and Pancreas Surgery
  • Division of Transplantation
(608) 263-0388

600 Highland Ave.
MC 7375
Madison, WI 53792-3284


  • MD, New York University, School of Medicine, New York, NY, 1987
  • Residency, General Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA, 1987-1994
  • Postdoctoral Research Fellow, Harrison Department of Surgical Research, Hospital of the University of Pennsylvania, Philadelphia, PA, 1990-1992
  • Fellow, Transplant Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, 1994-1996

Clinical Specialties

Dr. Odorico is certified by the American Board of Surgery. He specializes in pancreatic, islet cell, and multi-organ transplants.

Dr. Odorico provides a wide range of services including Kidney Transplant, Pancreas Transplant.

Research Interests

Dr. Odorico’s research focuses on stem cell biology and differentiation, developing novel stem cell-based strategies for treating diabetes, pancreas transplantation, and islet cell transplantation.
Dr. Odorico’s lab

Clinical Trials

Conversion from Immediate Release Tacrolimus to Envarsus XR® in Simultaneous Pancreas-Kidney Recipients: Assessment of functional, safety and quality of life outcomes (CIRTEN SPK)
Study sponsor: University of Wisconsin-Madison
Study funding provided by: Veloxis Pharmaceuticals
Jon S. Odorico, MD, Principal Investigator
10/18/2018 –present

Non Invasive Blood Test to Diagnose Acute Rejection After Pancreas and Kidney Transplantation: Pancreas and Renal Rejection Diagnosis Using Circulating Donor-Derived Cell-free DNA in Peripheral Blood (PANCDx)
Study funding provided by: CareDx
Jon S. Odorico, MD, Sub-Investigator
Subcontract Agreement Amendment under negotiation, we expect to start enrollment in the first quarter of 2020

Recent Publications

  • Delayed kidney graft function in simultaneous pancreas-kidney transplant recipients is associated with early pancreas allograft failure.
    Parajuli S, Muth BL, Astor BC, Redfield RR, Mandelbrot DA, Odorico JS, Djamali A, Kaufman DB
    Am. J. Transplant. 2020 Apr 19;
    [PubMed ID: 32306520]

  • Polyomavirus and cytomegalovirus infections are risk factors for grafts loss in simultaneous pancreas and kidney transplant.
    Aziz F, Jorgenson MR, Parajuli S, Zhong W, Hidalgo LG, Djamali A, Mandelbrot D, Odorico J, Sollinger H, Astor BC, Mohamed MA
    Transpl Infect Dis 2020 Feb 29; e13272
    [PubMed ID: 32112710]

  • Incidence and Outcomes of Significant Weight Changes After Pancreas Transplant Alone.
    Swanson KJ, Joachim E, Arunachalam A, Aziz F, Garg N, Mohamed M, Djamali A, Redfield RR, Kaufman DB, Odorico J, Mandelbrot D, Parajuli S
    Transplant Direct 2020 Mar; 6(3): e539
    [PubMed ID: 32195330]

  • Challenges of calcineurin inhibitor withdrawal following combined pancreas and kidney transplantation: Results of a prospective, randomized clinical trial.
    Stock PG, Mannon RB, Armstrong B, Watson N, Ikle D, Robien MA, Morrison Y, Odorico J, Fridell J, Mehta AK, Newell KA
    Am. J. Transplant. 2020 Feb 10;
    [PubMed ID: 32039559]

  • Hypertension, but not body mass index, is predictive of increased pancreatic lipid content and islet dysfunction.
    Tremmel DM, Feeney AK, Mitchell SA, Chlebeck PJ, Raglin SA, Fernandez LA, Odorico JS, Sackett SD
    Am. J. Transplant. 2020 04; 20(4): 1105-1115
    [PubMed ID: 31715064]

All Publications on PubMed